key: cord-0029058-16thfuzs
authors: Bąska, Piotr; Norbury, Luke J.
title: The Role of Nuclear Factor Kappa B (NF-κB) in the Immune Response against Parasites
date: 2022-03-02
journal: Pathogens
DOI: 10.3390/pathogens11030310
sha: dcbae322ec35c42a533ebaa0d8a40152a3889c43
doc_id: 29058
cord_uid: 16thfuzs

The immune system consists of various cells, organs, and processes that interact in a sophisticated manner to defend against pathogens. Upon initial exposure to an invader, nonspecific mechanisms are raised through the activation of macrophages, monocytes, basophils, mast cells, eosinophils, innate lymphoid cells, or natural killer cells. During the course of an infection, more specific responses develop (adaptive immune responses) whose hallmarks include the expansion of B and T cells that specifically recognize foreign antigens. Cell to cell communication takes place through physical interactions as well as through the release of mediators (cytokines, chemokines) that modify cell activity and control and regulate the immune response. One regulator of cell states is the transcription factor Nuclear Factor kappa B (NF-κB) which mediates responses to various stimuli and is involved in a variety of processes (cell cycle, development, apoptosis, carcinogenesis, innate and adaptive immune responses). It consists of two protein classes with NF-κB1 (p105/50) and NF-κB2 (p100/52) belonging to class I, and RelA (p65), RelB and c-Rel belonging to class II. The active transcription factor consists of a dimer, usually comprised of both class I and class II proteins conjugated to Inhibitor of κB (IκB). Through various stimuli, IκB is phosphorylated and detached, allowing dimer migration to the nucleus and binding of DNA. NF-κB is crucial in regulating the immune response and maintaining a balance between suppression, effective response, and immunopathologies. Parasites are a diverse group of organisms comprised of three major groups: protozoa, helminths, and ectoparasites. Each group induces distinct effector immune mechanisms and is susceptible to different types of immune responses (Th(1), Th(2), Th(17)). This review describes the role of NF-κB and its activity during parasite infections and its contribution to inducing protective responses or immunopathologies.

Parasites are a diverse group of organisms comprised of three major groups: protozoa, helminths, and ectoparasites. During the course of their evolution, they have gained the ability to live in or on hosts and gather food at the hosts' expense. They may feed on both humans and animals; up to 2.0 billion [1] people may suffer from parasitic infections, and losses in animal production are estimated at many US$ billions per year [2] . It is not in the interest of the parasite to kill the host, consequently chronic, long-lasting infections can be common.

The persistency of many infections occurs in part due to the immunomodulatory abilities of the parasites [3] . During the thousands of years of co-evolution with host organisms, parasites have learned to trick, evade and suppress the host immune system. Parasites' mechanisms of immunomodulation are very effective and diverse, and this has earned them the nickname "masters of regulation" [4] . Parasites can cleave antibodies [5] [6] [7] , Figure 1 . Schematic model of NF-κB activation through canonical and non-canonical pathways. Canonical activation involves TGF-β activated kinase-1 (TAK1) which phosphorylates Inhibitory Kappa B Kinase β (IKKβ) complexed with IKKα and IKKγ (NEMO). This leads to phosphorylation of the α Inhibitor of κB (IκBα), its detachment from the p56/p50 dimer, ubiquitination, and proteasomal degradation. Released p65/p50 dimer migrates to the nucleus and binds to DNA sequences leading to transcription of appropriate genes. During the noncanonical pathway, NF-κB-inducing kinase (NIK) phosphorylates the IKKα dimer which phosphorylates p100 leading to its disruption and release of the RelB/p52 dimer. The dimer migrates to the nucleus and regulates the transcription of particular genes.

Activation of the canonical pathway is mediated through TAK1 and has rapid and transient effects, whereas the noncanonical pathway is slow, persistent, and with the hallmark of NIK activation [32] . Moreover, the canonical pathway is activated by various stimuli including PAMPs, DAMPs, and numerous receptors, while the noncanonical pathways are induced by a specific set of receptors, e.g., B-cell-activating factor belonging to TNF family receptor (BAFFR), lymphotoxin β-receptor (LTβR), receptor activator for nuclear factor κB (RANK), TNFR2, Fn14, CD30, and CD27 [41] . Both pathways are indispensable for the appropriate regulation of the balance between immune tolerance and inflammation. Due to the number of potential NF-κB dimers [42] , and interactions with other factors [43] the role of NF-κB during the course of infections is very complicated. Both positive and negative implications during parasite infections are reviewed below and depicted in Figures 2 and 3 . Canonical activation involves TGF-β activated kinase-1 (TAK1) which phosphorylates Inhibitory Kappa B Kinase β (IKKβ) complexed with IKKα and IKKγ (NEMO). This leads to phosphorylation of the α Inhibitor of κB (IκBα), its detachment from the p56/p50 dimer, ubiquitination, and proteasomal degradation. Released p65/p50 dimer migrates to the nucleus and binds to DNA sequences leading to transcription of appropriate genes. During the noncanonical pathway, NF-κB-inducing kinase (NIK) phosphorylates the IKKα dimer which phosphorylates p100 leading to its disruption and release of the RelB/p52 dimer. The dimer migrates to the nucleus and regulates the transcription of particular genes. 

Malaria is a disease caused by Plasmodium spp. Over 40% of the human population is estimated to be at risk of infection [44] . A vast majority of cases occur in Africa, and despite a global trend towards reductions in the number of infections over recent decades, over 241 million malaria cases and 627,000 deaths were estimated to have occurred globally in 2020 [45] . Whether host responses contribute to pathology or protection can be hard to determine, and while proinflammatory responses to malaria infections are critical to controlling the disease, excessive inflammation is linked to pathology (Table 1) . NF-κB is a highly important orchestrator of the immune response during Plasmodium infections [46] [47] [48] . In general, during an infection NF-κB is increased and it has pivotal and specific roles in pathogenesis and the immune response, being implicated in several processes. Cerebral malaria is considered the most severe clinical complication of infection and pro- Figure 3 . The impact of helminths on NF-κB activity and outcomes. (A) B. malayi infection results in decreased NF-κB activity and induces M 2 and eventually M reg macrophages, while patients with lymphatic pathology show increased angiogenesis associated with NF-κB activation. H. polygyrus induces semi-maturation of DCs and induces Th 2 and regulatory events through modulation of NF-κB activity. Products released by T. spiralis affect NF-κB activity in LPS-activated macrophages, significantly reducing proinflammatory cytokine production. (B) T. solium larval antigens activate the NF-κB pathway in monocytes inducing chemokine release. M. corti antigens inhibit LPS-induced inflammatory phenotypes in microglia cells via NF-κB modulation. (C) F. hepatica tegumental antigens temporarily prevent LPS-induced NF-κB in DC, suppressing maturation. S. mansoni induces NF-κB activation in human hepatic stellate cells which is associated with liver fibrosis; a similar situation occurs in S. Japonicum-infected mice.

Malaria is a disease caused by Plasmodium spp. Over 40% of the human population is estimated to be at risk of infection [44] . A vast majority of cases occur in Africa, and despite a global trend towards reductions in the number of infections over recent decades, over 241 million malaria cases and 627,000 deaths were estimated to have occurred globally in 2020 [45] . Whether host responses contribute to pathology or protection can be hard to determine, and while proinflammatory responses to malaria infections are critical to controlling the disease, excessive inflammation is linked to pathology (Table 1) . NF-κB is a highly important orchestrator of the immune response during Plasmodium infections [46] [47] [48] . In general, during an infection NF-κB is increased and it has pivotal and specific roles in pathogenesis and the immune response, being implicated in several processes. Cerebral malaria is considered the most severe clinical complication of infection and proinflammatory cytokines, cytoadherence, and endothelial activation are considered to have roles in pathogenesis [49] . Exposure to P. falciparum-infected erythrocytes has been shown to induce nuclear translocation of NF-κB p65 in human brain microvascular endothelial cells in vitro, along with upregulation of the NF-κB activation cascade, of NF-κB subunits (p100, p105, c-REL, RELB) and NF-κB inhibitory proteins (IκBα, IκBε)-this results in increased proinflammatory chemokine/cytokine release (CCL20 and TNF-α) and intercellular adhesion molecule 1 (ICAM-1) surface expression [48, 50] . ICAM-1 is linked with the adhesion of infected erythrocytes to epithelial cells and the associated disease pathology. While this can occur in the brain, it can also occur in other organs. Upon exposure to extracellular vesicles containing P. vivax proteins, human spleen fibroblasts show upregulation of ICAM-1, linked to nuclear translocation of NF-κB [51] . This has been postulated to facilitate the formation of hidden parasite populations in the spleen relatively safe from control measures. Patients with cerebral malaria also show increased p65 translocation to the nucleus in neurons, glial cells, epithelial cells, and leukocytes [46] . These changes correlate with histopathological changes in the brain, with NF-κB p65 modulating apoptosis in brain endothelial cells and intravascular leukocytes during cerebral malaria [46] . NF-κB has also been shown to regulate apoptosis in Kupffer cells and lymphocytes in the liver during severe P. falciparum infection [52] . Other cell types also show upregulation of NF-κB pathways during infection. Increased translocation of p65 and p50 to the nucleus and degradation of IκBα occurs in monocytes following exposure to trophozoites or hemozoin. This coincides with enhanced activity of monocyte matrix metalloproteinase-9 and increased proinflammatory cytokine production, effects also important to malaria pathogenesis [53] . Interestingly, it has been reported that while significantly elevated active p65 levels occur in peripheral blood mononuclear cells (PBMCs) of P. vivax patients and P. falciparum patients with mild symptoms, those with severe P. falciparum malaria only showed increased levels of active p65 after treatment, with NF-κB expression being negatively correlated with IL-10 levels [54] . During infections, the malaria parasite can induce upregulation of NF-κB pathways in a variety of cell types. The full role of NF-κB during malaria infection is dependent on cell type and likely influenced by parasite strain and the genetics of the host. While further study is needed to fully elucidate NF-κB's roles, it is evident that during severe infections there is a link between NF-κB upregulation and several effects that play a role in malaria pathogenesis. Enhanced activity of MMP-9, enhanced production of proinflammatory cytokines TNF and IL-1β. 

The Trypanosoma genus is comprised of several species, but only Trypanosoma cruzi and T. brucei (T. b. gambiense and T. b. rhodesiense) cause disease in humans, Chagas disease and sleeping sickness, respectively. Other species cause disease in animals and may also be models for human infection. Both Chagas disease and sleeping sickness are significant problems in sub-Saharan and tropical climates. Trypomastigotes can infect a range of cell types ( Table 2) . Several trypanosome species have been shown to activate NF-κB in epithelial cells, endothelial cells, and fibroblasts [55, 56] . This involves a rapid increase in p65 and p65 translocation to the nucleus, as well as phosphorylation of IKKα/β, resulting in induction of a pro-inflammatory response through NF-κB -dependent expression of TNF-α, IL-1β, and IL-6 cytokines, nitric oxide, and adhesion molecules (E-selectin, VCAM-1, and ICAM-1) [55] [56] [57] [58] Activation of NF-κB is a determinator of T. cruzi intracellular survival and tissue specificity. The ability for T. cruzi to induce NF-κB activation is highly dependent Pathogens 2022, 11, 310 7 of 24 on cell type and appears to be inversely correlated with a cell's susceptibility to infection. The high susceptibility of muscle cells to infection by T. cruzi has been proposed to be in part due to a failure to induce NF-κB activation [55] . Activation of endothelial cells via the NF-κB pathway occurs with intact trypomastigotes, however, trypanosome trans-sialidases have also been shown to mediate this activity via α-2,3 sialylated receptors [56] . Toll-like receptors (TLRs), likely through recognition of parasite glycoisnositolphospholipids and glycosylphosphatidyl inositol, have also been shown to be involved in T. cruzi-mediated increased NF-κB and the resultant pro-inflammatory response [57, 59, 60] . Other receptors that recognize T. cruzi and are involved in subsequent activation of NF-κB have been identified; macrophage galactose-C type lectin (MGL1) receptor is critical for the optimal activation of macrophages during T. cruzi infection. MGL1 is proposed to recognize soluble T. cruzi Lysate Antigen (TcAg) [61] . A trypanosome antigen that can disrupt the protective host response via modulation of NF-κB is cruzain from T. cruzi. Cruzain cleaves p65, this prevents macrophage activation during early infection, facilitating parasite survival and the spread of infection [62] . For efficient parasite removal, the immune system must maintain a balance between effective Th 1 and Th reg immune responses. A Th 1 response, mediated mainly by TNF-α may be efficient at clearing the parasite, but without appropriate regulating mechanisms (mainly through IL-10) exacerbated inflammation may lead to increased pathology and disease severity. This is evident in mice with impaired IL-10 production, which are less resistant to T. congolense and T. brucei infection and show higher degrees of inflammation and immunopathologies due to dysregulated immunoregulation [63] . A major orchestrator of this regulation is NF-κB, with p65/p50 and p50/p50 complexes important players in regulating pro-and anti-inflammatory pathways, respectively [64] . p50 plays a role in down-regulation of the inflammatory response [65] , and p50 −/− mice fail to maintain an appropriate balance between Th reg /Th 1 , leading to increased liver injury during T. congolense infection, associated with TNF-α overproduction [66] . While induction of NF-κB pathways to promote proinflammatory responses can confer protection against trypanosomes as outlined above, a prolonged response can confer pathogenicity. T. cruzi-induced proinflammatory responses in human colonic epithelial cells have been linked to Megacolon, a major pathology of Chagas disease [57] . Additionally, activation of NF-κB -dependent inflammatory responses in cardiomyocytes, and vascular endothelial cells by T. cruzi may contribute to vascular dysfunction and injury, and chronic cardiomyopathy [58, 67, 68] . IL-10, TNF-α, and nitric oxide (NO) production.

T. cruzi [68] •

Thoracic aortic rings from infected C57BL/6 mice Increase in expression of NF-κB p65.

Increased expression of COX-2 and thromboxane synthase in aortas leading to vascular contraction. Endothelial cell activation, and subsequent pro-inflammatory response-production of cytokines IL-1β and IL-6, nitric oxide and expression of adhesion molecules.

T. cruzi [67] • Trypomastigotes Human cardiomyocytes (AC16) Increased nuclear translocation of p65, enhanced expression of NF-κB dependent genes.

Enhanced mRNA expression of TNF-α and IL-β.

T. cruzi [55] • Trypomastigotes T. cruzi [58] • Trypomastigotes Human umbilical vein endothelial cells (HUVEC)

Nuclear translocation of active NF-κB (p65 and p50).

Induction of vascular cell adhesion molecule 1 (VCAM-1) and E-selectin and the upregulation of intercellular adhesion molecule 1 (ICAM-1).

T. cruzi [62] • Wild T. cruzi strain • Cruzain-deficient T. cruzi strain J774 macrophages Proteolytic cleavage of NF-κB p65 by cruzain.

Impairment of macrophage activation pathways (reduced IL-12, increased L-arginase).

Toxoplasma gondii is an obligate intracellular Apicomplexan parasite able to inhabit a broad spectrum of mammals [69] . It has been estimated that up to one-third of the world's population may be seropositive to this parasite [70] . The host-pathogen interplay and molecular basis of host resistance are complicated, but a pattern showing a key role for a balance between IL-1β, TNF-α, IL-12, and IFN-γ exists [71] [72] [73] [74] [75] . Upon disruption of this balance the protective but over-expressed Th 1 cytokines (IFN-γ, IL-1β, TNF-α, and IL-12) lead to immunopathologies [76] . NF-κB is involved in the positive and negative regulation of these cytokines [77] [78] [79] and is a crucial factor required for eliciting a protective response (Table 3 ). This is demonstrated by the fact that RelB −/− mice develop impaired innate and adaptive immune responses and do not survive T. gondii infection [80] . T. gondii infection in mice results in a global increase in NF-κB activity [81] . However, most data indicate T. gondii induces a suppressing NF-κB phenotype in infected macrophages in mice leading to delayed IL-12 production and failure to produce TNF-α. Despite increased p65 phosphorylation [82] , and IκBα phosphorylation [83] , translocation of p65 and c-Rel is not observed [81, 83, 84] . This process of NF-κB suppression requires active invasion by the parasite [84] , and recently downregulation of miR-187 by the parasite has been implicated in p65 phosphorylation and mediation of IL-12 expression [82] . On the other hand, infected human monocytes show an activated phenotype with an increase in both p65 phosphorylation [85] and p65 translocation [74] . This leads to IL-1β induction [86] , and also requires active invasion by the parasite, with dense granule protein GRA15 playing a role, and parasite strain lineage also important [74] . LPS-induced IL-1β levels also appear unaffected in T. gondii infected monocytes [86] . This strain has a relative inability to inhibit the NF-κB pathway. In vitro: little or no production of IL-12 and TNF-α; LPS triggering unable to promote IL-12 and TNF-α production.

Of course, it is worth remembering that the use of different models may produce different results. A well-established model to investigate the immune response is based on simultaneous stimulation of cells with lipopolysaccharide (LPS) and the factor under investigation, to observe if there is an abrogation of the LPS-induced proinflammatory response [93, 94] . Conflicting results have been reported for mouse macrophages, some indicating T. gondii has the ability to abolish LPS-induced p65 translocation [83] , whereas others indicate LPS-induced p65 translocation is unaffected, as is LPS-induced nuclear NF-κB-binding activity [92] . Nevertheless, the consensus is that T. gondii infection interferes with NF-κB activation at a step downstream of these processes and effectively dampens the host immune response, facilitating parasite survival and multiplication [82] [83] [84] 92] . Another LPS-activated immune cell population-neutrophils-also skew their phenotype towards suppression when infected with T. gondii; dampened inflammasome activity and IL-1β release is associated with reduced p65 (Ser536) phosphorylation and inhibition of IκBα degradation-classical hallmarks of reduced NF-κB activity [86] . Data from non-immune cells also confirms T. gondii's abilities to deactivate NF-κB. Despite human fibroblasts showing some signs of increased NF-κB activity upon T. gondii exposure, like IKK-dependent degradation of IκB, the phenotype is actually one of reduced transcription due to altered downstream processes: reduced phosphorylation of p65 and no p65, p50, or c-Rel nucleus accumulation [89] . Phosphorylation of p65 at Ser468 by virulence factor ROP18, targeting it for degradation, and blocking nuclear translocation has also been demonstrated as a means to inhibiting the host NF-κB pathway in fibroblasts and macrophages [91] . These results highlight the importance of phosphorylation as a means by which the parasite can mediate NF-κB pathway inhibition [37] .

This contrasts with a report of mouse fibroblasts which show a more activated phenotype, with induced p50 and p65 translocation to the nucleus, enhanced DNA binding by p50, p65, RelB, and p52, and phosphorylation (though no observed degradation) of IκB upon T. gondii infection [90] . This response was reported to result in an anti-apoptotic phenotype. NF-κB is considered an anti-apoptotic factor, therefore, despite efforts by the parasite to dampen NF-κB activity complete abrogation of activity is not likely to be in the interest of the parasite; apoptosis would destroy the niche it lives in-the cell [95] . Some Toxoplasma-infected cells appear resistant to apoptosis [96] and show NF-κB dependent anti-apoptotic gene expression patterns [90] ; moreover, NF-κB deprived mice (p65 −/− ) are unable to prevent apoptosis hallmarks in infected cells [97] . While our understanding of the interplay between this parasite and NF-κB is still in its infancy, the findings presented here indicate T. gondii has developed sophisticated mechanisms to manipulate host NF-κB to effectively modulate the host response to facilitate parasite survival. The dampening of host responses is also likely to minimize immune-mediated host pathology.

Leishmania is a protozoan parasite that inhabits phagolysosomes [98] . Data shows that 12 million people worldwide suffer from leishmaniasis [99] . Clinical manifestations of the disease depend on the Leishmania species and are classified as: cutaneous, visceral, mucocutaneous, and diffuse cutaneous leishmaniasis [100] . Leishmania resides in host macrophages, as well as neutrophils and inflammatory monocytes [99] . Like other protozoan parasites, Leishmania has developed mechanisms to survive in the host and evade the immune response. A coordinated immune response (Table 4 ) is required to eliminate Leishmania, and effective parasite removal is associated with proinflammatory IL-12, TNF-α, and IFN-γ, whereas IL-4, IL-10, IL-13, and TGF-β are associated with parasite survival [101] . The key cytokine believed to be involved in parasite survival is IL-10, with IL-10 knockout (KO) mice resistant to infection [102, 103] . It is therefore not surprising that the parasites' efforts at dampening the proinflammatory response, through increased IL-10 release are intense. The pivotal role of NF-κB in immune response regulation, including as a positive and negative regulator of macrophage gene expression [104] , also key to Leishmania invasion, means NF-κB offers an attractive target for the parasite to manipulate. Upon contact with L. major amastigote, human monocytes preferentially induce p50/p50 and p50/c-Rel, with inhibition of p50/p65 translocation [105] . p50/p50 complexes are associated with IL-10 [64] , and infected monocytes release increased concentrations of both IL-10 and TNF-α [105] . While IL-10 is expected to be beneficial for the parasite and is implicated in Leishmania survival, TNF-α is involved in inflammation and is putatively protective. Interestingly, infection of macrophages by L. major promastigotes results in inhibition of IL-12, a response beneficial to the parasite, though this is not due to inhibition of NF-κB activation [106] . Leishmania parasites may modulate the NF-κB pathway in numerous ways and for various reasons. Upon infection of human or mouse macrophages, the promastigote stage of several Leishmania species (but not L. aethiopica or L. tarentolae) can cause cleavage of p65 into p35. This is dependent on Leishmania protease gp63. p35 is involved in the expression of specific chemokines and the parasite has been proposed to induce those favorable to its survival [98, 109] . Cleavage of p65 to p35 has also been reported following dendritic cell infection by L. infantum promastigotes [111] . L. aethiopica amastigotes have been shown to manipulate a variety of signaling pathways, including NF-κB, in human macrophages during spreading [109] . This results in reduced p65 expression and phosphorylation (Ser32/36) of IκB, indicating downregulation of NF-κB. This down-regulation of NF-κB leading to cell apoptosis is expected to facilitate the spread of the parasite [109] . Conversely, decreased expression of IκB was also reported which is expected to induce p65 translocation and NF-κB pathway activation and may indicate pleiotropic impacts of Leishmania on NF-κB pathways.

Leishmania species can promote silent infections under certain conditions; this can sometimes be achieved through the modulation of NF-κB pathways. It has been observed that when L. donovani promastigotes infect mouse macrophages, there is no change in the expression of cytosolic or nuclear p50 or p65 expression in response. This results from active downregulation of NF-κB, mediated through Hypoxia Inducible Factor-1α (HIF-1α) and miR-210 [110] . This leads to decreased pro-inflammatory cytokine expression and NO production by the macrophages and facilitates parasite survival. The generation of a permissive environment is also evident upon L. amazonensis amastigote infection of mouse dendritic cells. The infection leads to pleiotropic inhibition of TLR/NF-κB/NLRP3 pathways, promoting transcriptional activation of the alternative NF-κB pathway which is proposed to lead to MHC class I-restricted antigen presentation and stalling of dendritic cell maturation [107] . Stalled mouse dendritic cell maturation is also evident upon infection by L. infantum promastigotes [111] . Here the parasite impairs NF-κB through cleavage of p65, although no impact on IkBα expression was reported.

It is difficult to draw one clear conclusion regarding the processes and roles of NF-κB modulation during Leishmania infection based on the varied data in the literature. Moreover, there may not even be one clear conclusion. Authors have analyzed various laboratory models, cell types, and different Leishmania species, hence contrasting results may be expected. This is supported by the results of Nogueira et al. who evaluated responses to various Leishmania species (L. braziliensis, L. infantum, L. amazonensis) and showed that only L. amazonensis was able to induce p65 translocation to the nucleus and a pro-inflammatory response in a particular laboratory model [108] . The variability among species to cleave p65 to p35 should also be noted [98, 109] . Species-specific and stage-specific variations, as well as the development of effective immune responses complicate the situation; nevertheless, from the known data emerges a pattern which generally indicates that Leishmania modulates the NF-κB pathway towards a dampening of TNF-α expression and production of an environment that facilitates parasite survival.

Helminths are a divergent group of multicellular parasites (Cestoda, Nematoda, Trematoda). Due to their size, like protozoan parasites, they cannot be neutralized by phagocytosis; moreover, their abilities to trick and evade the host immune system allow them to efficiently regulate the immune response towards a Th 2 type. This is beneficial for the parasite and also arguably the host-the parasite survives and gains reproductive success while the host does not suffer from immunopathologies. The ability to dampen Th 1 responses has led to an exploration of the use of helminths (or their products) as treatments for allergies and autoimmune diseases (as reviewed elsewhere [112, 113] ). The high prevalence of helminth infections has also led to research regarding the development of vaccines. These have led to numerous studies regarding vaccine trials, the impacts of helminth antigens on symptoms of autoimmune diseases (or allergies), and cytokine patterns during infections, yet only a small proportion of the research has focused on characterizing the intracellular mechanisms of the immune response in the context of NF-κB and this topic seems to have been relatively neglected to date.

Helminth parasites excrete and secrete a range of molecules during host invasion. These molecules function at the host-parasite interface and are often how parasites modulate the host immune response ( Table 5 ). The excretory-secretory product (ES) from Taenia crassiceps is known to skew immune responses through the downregulation of proinflammatory pathways. One way T. crassiceps can achieve this is through modulation of dendritic cells, which play a major role in the initiation of Th 2 polarization [114] . T. crassiceps ES can modulate signaling in dendritic cells, including in the NF-κB pathway, leading to significantly attenuated LPS-induced p65 phosphorylation. This contributes to the blocking of dendritic cell maturation and a dampening of proinflammatory IL-12 and TNF-α, which affects eventual T-cell responses [114] . Mesocestoides corti soluble antigens also exhibit NF-κB-modulated immunosuppressive properties. M. corti helminth soluble factors (HSFs) inhibit LPS-induced p65 phosphorylation and acetylation in microglia leading to abrogation of IL-6 and TNF-α release [115] . This parasite suppression of host inflammation and immunity provides another example of how parasites may actively modulate host responses to produce asymptomatic phases of the disease. Parasite somatic antigens function to maintain the parasite's metabolism, physiological processes and regulate homeostasis, and generally have less contact with the host immune system. While parasites actively suppress host immune responses, parasite damage or death can sometimes lead to an inflammatory response and pathology. This may occur during Taenia solium infections. T. solium larval somatic antigens activate the NF-κB pathway in human monocytes, through increased IkB-α degradation and enhanced DNA binding by p65, p50, or c-Rel. This results in a release of the chemokines CXCL8 and CCL2, which may have a role in immune cell recruitment, which may be a factor associated with inflammation and pathology [116] . Table 5 . Cestodes impact on NF-κB activity and outcomes.

Taenia crassiceps [114] •

Tc-ES did not induce p65 phosphorylation (Ser536), but attenuated LPS-induced p65 phosphorylation (Ser536).

Inhibition of DC maturation, cytokine production, and the ability of LPS-treated DCs to prime Th 1 responses.

Taenia solium [116] • Larval antigen (Ts-Ag) Human primary monocytes Increased degradation of IkB-α but not IkBβ; increased DNA binding by p65, p50, and cRel.

Induced CCL2, CXCL8, and CCL3 secretion.

•

Decrease in LPS-induced p65 phosphorylation and acetylation.

Inhibition of LPS-induced secretion of IL-6 and TNF-α cytokines.

Taenia crassiceps [117] • Fractionated Taenia glycans • Lewis sugars Mouse spleen cells p65 level increased, p50 level was not affected.

Release of IFN-γ from spleen cells stimulated with N glycans upon stimulation with Taenia glycans; Lewis X sugars upregulated p65 expression and had no impact on p50 expression.

Insights into the role of the NF-κB pathway during nematode infections come from the well-established model organism Trichuris muris. A detailed and nuanced role for NF-κB in mounting a protective response has been revealed during in vivo experiments (Table 6) . Mice able to clear T. muris infections show enhanced NF-κB activity with elevated levels of IL-4 and IL-13 and lower levels of IFN-γ, demonstrating a protective Th 2 response and skewing away from a susceptible Th 1 response [118] . c-Rel KO mice maintain resistance to infection, whereas p105/50 (NF-κB1) and p100/52(NF-κB2) KO mice develop chronic infection, with the highest immunopathologies observed among p105/50 deficient mice, correlating with elevated IFN-γ concentrations [118] . p50/p50 complexes are associated with regulatory IL-10 [64, 65, 119] suggesting a role for IL-10 in controlling intestinal inflammation. The data from KO studies indicate roles for components of the NF-κB pathway and demonstrates NF-κB utilization during helminth infections as an inductor of a protective regulatory response. Colonic epithelium cells show increased p65 phosphorylation upon exposure to T. muris ES which leads to the release of proinflammatory factors [120] . Trichinella spiralis [124] • ES products of L1 muscle larvae Mouse macrophages (RAW264.7)

Reduced LPS-induced p65 expression levels.

Increased regulatory IL-10, reduced LPS-induced proinflammatory (TNF-α and IL-12) and regulatory cytokines (IL-10).

Trichinella spiralis [125] • ES of muscle larvae (ML) and adult worms ( Relative lack of DC activation: TNF-α, TGF-β, IL-6, MCP-1 unchanged, decreased expression of regulatory cytokine (IL-10) and proinflammatory factor (IL-12p70), increased expression of IL-4 (Th 2 type).

• Adult stage somatic antigens (Hp-Ag)

Various changes in p65 and p50 levels in cytoplasm and nucleus nucleus.

Inhibition of apoptosis.

During T. spiralis infection, NF-κB (though P2X7R-mediated NLRP3 activation) modulates the killing capacity of macrophages, with NF-κB downregulation resulting in decreased killing capacity [123] . T. spiralis ES from various life stages can reduce LPS-induced p65 expression and nuclear translocation [124, 125] . The resulting inhibition of LPS-induced pro-inflammatory (TNF-α, IL-1β, IL-6, IL-12) cytokine expression, and induction of regulatory cytokines (IL-10, TGF-β) indicates a role during infections in the modulation of macrophage responses towards phenotypes conducive to worm survival and host health [124, 125] .

Modulation of macrophage regulation is also observed during Brugia malayi infections. Downregulation and impaired activation of NF-κB-p65 and NF-κB-p50/105 in mouse macrophages during the course of infection contributes to macrophage polarization towards M 2 and M reg phenotypes and downregulation of proinflammatory IL-12 release and increased secretion of Th 2 /Th reg cytokines: IL-4 and IL-10, respectively [126] . IL-10 and IL-12 release is also impaired in human DCs exposed to B. malayi microfilariae [130] ; however, pathologies during infection are associated with increased Th 1 /Th 17 responses [131] and enhanced angiogenesis [132] . NF-κB is involved in both angiogenesis [133] and inflammation [134] regulation. Although the basic levels of angiogenic factors do not differ between asymptomatic and filarial lymphedema (lymphatic pathology) patients, the cells from lymphedema patients produce higher levels of vascular endothelial growth factor (VEGF)-C [127] and NF-κB activation has a role in elevated angiogenic growth factor production, and associated pathology, in these patients [127] . While several nematode derived molecules may contribute to the development of angiogenesis, Jothi et al. identified a prominent angiogenic factor from B. malayi: Asparaginyl-tRNA Synthetase [135] , which acts through the NF-κB pathway [121] .

Prevention of DC maturation, upon incubation with L4 larvae of Heligmosomoides polygyrus [128] and the ability of adult stage H. polygyrus somatic antigens to inhibit proliferation and apoptosis of host immune cells [129] are other examples where parasite regulation of the NF-κB pathway is utilized by nematodes to modulate host immune responses and facilitate survival.

The formation of liver granuloma and fibrosis following egg deposition is a serious pathology that can occur during schistosomiasis. The TNF-α level, raised by parasite egg antigens, is positively correlated with parasite burden [136] , and increased TNF-α mediates increased morbidity [137] . As the NF-κB pathway is involved in TNF-α expression, this indicates increased NF-κB activity. While no data are available from immune cells (Table 7) , liver and colonic cells show increased p65 expression, translocation to the nucleus, and phosphorylation (Ser276) [136, 138, 139] , with involvement of NF-κB in apoptosis. The role of NF-κB in pathology is supported by the fact that its inhibition in vivo prevents granuloma and fibrosis [140, 141] . Fasciola hepatica uses a variety of molecules to modulate host immune responses to facilitate its survival and manage host pathology, driving antiinflammatory responses and Th 1 suppression; it is considered a potent immune modulator. Some, but not all of the immune-modulatory effects induced by the parasite involve interaction with the NF-κB pathway. F. hepatica tegumental antigens (Teg) prevent NF-κB activation (p65 expression) in dendritic cells. This leads to suppression of dendritic cell maturation and function-suppressing induction of proinflammatory cytokines and cell surface markers [142] . The ability of F. hepatica to modulate responses [93, 143, 144] has led to attempts to use its components to treat a range of diseases and conditions. An example is the use of F. hepatica extracellular vesicles (EV) to treat colitis. EV were shown to suppress induced p65 translocation in a mice colitis model, effectively reducing the release of proinflammatory cytokines TNF-α, IL-6, and IL-17A, and attenuating clinical symptoms of colitis [145] . F. hepatica EV, Teg, and ES are comprised of a variety of molecules and their action is a sum of the action of all the antigens present. Therefore, these antigens may impact NF-κB in various ways. Two ES components, glutathione S-transferases (GST) and fatty acid binding protein (FABP) have separately been shown to be able to block LPS-induced NF-κB-dependent gene expression [146] [147] [148] . These molecules can suppress macrophage LPS-induced pro-inflammatory cytokines, activate a suppressive dendritic cell phenotype, and induce anti-inflammatory effects that attenuate septic shock and promote survival in a mouse model [146] [147] [148] . NF-κB shows significant role during the course of schistosomiasis.

Fasciola hepatica [145] • Secreted extracellular vesicles (Fh-EV) Colitic mice

Diminished p65 expression in response to Fh-EV in colitic mice.

Protective effect of Fh-EV:

amelioration of pathological colitis symptoms and reduced the amount of pro-inflammatory cytokines.

Fasciola hepatica [142] • Tegumental antigen (Fh-Teg) Mouse bone marrow-derived DCs Suppressed LPS-induced expression of p65.

Fh-ES suppressed LPS-induced IL-12p70, IL-10 and TNF-α release; modulated LPS-stimulated DC cytokine production and cell surface marker expression.

Fasciola hepatica [147] • Native • F. hepatica glutathione S-transferase (nFh-GST)

Mouse bone-marrow derived macrophages; Mice with induced septic shock, THP-1 cells Blocked TLRs from inducing NF-κB activation.

Reduced expression of LPS induced mRNA encoding IL-1β and TNF-α and release of IL-1β, IL-12p70, IL-6, IFN-γ, TNF-α and IL-2.

Fasciola hepatica [148] • F. hepatica fatty acid binding protein (Fh-12)

Mouse bone-marrow derived macrophages; Mice with induced septic shock, THP-1 cells, HEK293 cells Blocked LPS-induced NF-κB activation.

Reduced mRNA expression encoding IL-1β, IL-12p35, IL-12p40, TNF-α, IL-6, NOS-2 Reduced release of GM-CSF, IL-12p70, IL-3, IL-9, IL-10, IL-15, TNF-α and IFN-γ.

Fasciola hepatica [146] • F. hepatica sigma class glutathione transferase (rFh-GST-si); • F. hepatica cathepsin L (rFh-CL1)

Mouse DC and HEK293 cells rFh-GST-si, (but not rFh-CL1) increased p65 phosphorylation and NF-κB activation.

Induction of IL-6, IL-12p40, and MIP-2, but also prevented IL-17 and IL-23 release.

Fasciola hepatica [150] • F. hepatica cathepsin L (Fh-CL3)

No change in p65 expression and IκB-α.

Increased release of IL-1β and IL-18 by NLRP3 dependent mechanism.

Schistosoma mansoni [151] • Infected mice Liver cells Increase in p65 expression and translocation to nucleus.

Possible role of p65 in inhibiting apoptosis.

The NF-κB pathway is vital in regulating immune function and it plays an important role during infections by parasites, being integral to the formation of protective responses, or indeed pathologies. For example, NF-κB is pivotal to the induction of protective proinflammatory responses against trypanosomes and to the activation of macrophages during Leishmania or T. cruzi infections. Alternatively, hosts deficient in NF-κB pathway elements or unable to appropriately activate or regulate NF-κB pathways are often more susceptible to infections or pathologies. This has been demonstrated with T. gondii [80] , T. muris [118] , and trypanosome infections [63] , while the high susceptibility of muscle cells to T. cruzi infection is proposed to be linked to a failure to induce NF-κB activation [55] . Altered NF-κB activation in certain cell types during parasite infections can also lead to increased pathology, as observed in the brain in cases of cerebral malaria [32] .

The wide impact of NF-κB on various processes and in numerous cell types and its importance to mounting effective immune responses means that modulation of NF-κB pathways represents a vital strategy for many parasites to employ to facilitate survival. As such, parasites have evolved numerous strategies to either up-or down-regulate NF-κB. These include, but are not limited to, direct phosphorylation of NF-κB pathway proteins or their inhibitors [91] , binding of certain receptors to activate specific pathways [56, 57, 61] , or cleavage of NF-κB proteins via parasite proteases [62, 98, 111] . While each modulates NF-κB activity, the resulting outcomes of these actions are dependent on the cell types involved and whether NF-κB activity is increased or decreased.

The data presented in this review demonstrates that NF-κB has many crucial roles, including many essential to mounting an effective response against protozoan and metazoan parasites. By presenting several relevant host-parasite interactions involving parasite modulation of the NF-κB pathway we have highlighted how it is a target for parasites to create an environment within the host conducive to survival. We hope this has shed new light on this important regulator of immunity for the reader. 

The authors declare no conflict of interest.

Helminths and intestinal barrier function

Projected economic losses due to vector and vector-borne parasitic diseases in livestock of india and its significance in implementing the concept of integrated practices for vector management

The interplay of helminthic neuropeptides and proteases in parasite survival and host immunomodulation

Helminth parasites-Masters of regulation

Fasciola hepatica: Parasite-secreted proteinases degrade all human IgG subclasses: Determination of the specific cleavage sites and identification of the immunoglobulin fragments produced

Identification and characterization of a cathepsin L-like cysteine protease from Taenia solium metacestode

Pathogens 2022

Developmentally regulated secretion of cathepsin L-like cysteine proteases by Haemonchus contortus

Fasciola hepatica products induce apoptosis of peritoneal macrophages

Excretory-secretory products from Fasciola hepatica induce eosinophil apoptosis by a caspase-dependent mechanism

Recombinant Sj16 from Schistosoma japonicum contains a functional N-terminal nuclear localization signal necessary for nuclear translocation in dendritic cells and interleukin-10 production

The Schistosoma mansoni T2 ribonuclease omega-1 modulates inflammasome-dependent IL-1β secretion in macrophages

Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway

Recent Advances in Understanding the Inflammatory Response in Malaria: A Review of the Dual Role of Cytokines

Cytokine production and signalling in human THP-1 macrophages is dependent on Toxocara canis glycans

Toxocara canis mucins among other excretory-secretory antigens induce in vitro secretion of cytokines by mouse splenocytes

Interleukin-32γ in the Control of Acute Experimental Chagas Disease

Trypanosoma cruzi Induces B Cells That Regulate the CD4+ T Cell Response

Modulation of Host Immunity by Helminths: The Expanding Repertoire of Parasite Effector Molecules

Immunomodulation by helminths: Intracellular pathways and extracellular vesicles

Helminth-induced apoptosis: A silent strategy for immunosuppression

Dendritic cells and parasites: From recognition and activation to immune response instruction

Remote regulation of type 2 immunity by intestinal parasites

Helminth extracellular vesicles: Interactions with the host immune system

C7ORF41 Regulates Inflammation by Inhibiting NF-κB Signaling Pathway

Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2

The role of the transcription factor Nuclear Factor-kappa B in thyroid autoimmunity and cancer

Nuclear transcription factor-κB as a target for cancer drug development

A key role for NF-κb transcription factor c-rel in T-lymphocyte-differentiation and effector functions

The NF-kappaB family of transcription factors and its regulation

The non-canonical NF-κB pathway in immunity and inflammation

Structure of the nuclear factor κB-inducing kinase (NIK) kinase domain reveals a constitutively active conformation

Canonical and non-canonical JAK/STAT transcriptional targets may be involved in distinct and overlapping cellular processes

Transcriptional regulation via the NF-κB signaling module

Regulation of Nuclear Factor-kappaB Function by O-GlcNAcylation in Inflammation and Cancer. Front

The Regulation of NF-κB Subunits by Phosphorylation

NF-κB in immunobiology

Stretching the Function of Innate Immune Cells

Interplay between Non-Canonical NF-κB Signaling and Hepatitis B Virus Infection

Non-canonical NF-κB signaling pathway

Chapter 24 NF-KappaB Dimers in the Regulation of Neuronal Survival

Regulation of the NF-κB-mediated transcription of inflammatory genes

Malaria Molecular Epidemiology: An Evolutionary Genetics Perspective

Nuclear factor kappa B modulates apoptosis in the brain endothelial cells and intravascular leukocytes of fatal cerebral malaria

Gene expression profiling in blood from cerebral malaria patients and mild malaria patients living in Senegal

Plasmodium falciparum-infected erythrocytes induce NF-κB regulated inflammatory pathways in human cerebral endothelium

Cerebral malaria Mysteries at the blood-brain barrier

Plasmodium falciparum-infected erythrocytes increase intercellular adhesion molecule 1 expression on brain endothelium through NF-κB

Plasma-derived extracellular vesicles from Plasmodium vivax patients signal spleen fibroblasts via NF-kB facilitating parasite cytoadherence

Liver changes in severe Plasmodium falciparum malaria: Histopathology, apoptosis and nuclear factor kappa B expression

Role of the NF-κB transcription pathway in the haemozoin-and 15-HETEmediated activation of matrix metalloproteinase-9 in human adherent monocytes

Activation of nuclear factor kappa B in peripheral blood mononuclear cells from malaria patients

Cell-specific activation of nuclear factor-κB by the parasite Trypanosoma cruzi promotes resistance to intracellular infection

Identification of Trans-Sialidases as a Common Mediator of Endothelial Cell Activation by African Trypanosomes

Phospho-proteomic analysis of primary human colon epithelial cells during the early Trypanosoma cruzi infection phase

Infection of endothelial cells with Trypanosoma cruzi activates NF-κB and induces vascular adhesion molecule expression

Expression of Functional TLR4 Confers Proinflammatory Responsiveness to Trypanosoma cruzi Glycoinositolphospholipids and Higher Resistance to Infection with T. cruzi

The immune response to Trypanosoma cruzi: Role of toll-like receptors and perspectives for vaccine development

MGL1 Receptor Plays a Key Role in the Control of T. cruzi Infection by Increasing Macrophage Activation through Modulation of ERK1/2, c-Jun, NF-κB and NLRP3 Pathways

The trypanosoma cruzi protease cruzain mediates immune evasion

Experimental African trypanosomiasis: IFN-γ mediates early mortality

Molecular mechanisms of interleukin-10-mediated inhibition of NF-κB activity: A role for p50

Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB

IL-10 limits production of pathogenic TNF by M1 myeloid cells through induction of nuclear NF-κB p50 member in Trypanosoma congolense infection-resistant C57BL/6 mice

Trypanosoma cruzi induces the reactive oxygen species-PARP-1-RelA pathway for up-regulation of cytokine expression in cardiomyocytes

Mechanisms of vascular dysfunction in acute phase of Trypanosoma cruzi infection in mice

The history of Toxoplasma gondii-The first 100 years

Role of TNF and IL-1 in infections with Toxoplasma gondii

Cutting Edge: IL-12 Is Required for the Maintenance of IFN-γ Production in T Cells Mediating Chronic Resistance to the Intracellular Pathogen, Toxoplasma gondii

Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection

Human innate immunity to Toxoplasma gondii is mediated by host caspase-1 and ASC and parasite GRA15

In the belly of the beast: Subversion of macrophage proinflammatory signalling cascades during Toxoplasma gondii infection

In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha

NF-κB signaling in inflammation

NF-κB is a negative regulator of IL-1β secretion as revealed by genetic and pharmacological inhibition of IKKβ

An NFκB activity calculator to delineate signaling crosstalk: Type I and II interferons enhance NFκB via distinct mechanisms

The NF-kappa B family member RelB is required for innate and adaptive immunity to Toxoplasma gondii

Suppression of NF-κB activation by infection with Toxoplasma gondii

Delayed IL-12 production by macrophages during Toxoplasma gondii infection is regulated by miR-187

Toxoplasma gondii Tachyzoites Inhibit Proinflammatory Cytokine Induction in Infected Macrophages by Preventing Nuclear Translocation of the Transcription Factor NF-κB

Mechanism of entry determines the ability of Toxoplasma gondii to inhibit macrophage proinflammatory cytokine production

Toxoplasma gondii activates a Syk-CARD9-NF-κB signaling axis and gasdermin Dindependent release of IL-1β during infection of primary human monocytes

Evasion of Human Neutrophil-Mediated Host Defense during Toxoplasma gondii Infection

Toxoplasma gra16 inhibits nf-κb activation through pp2a-b55 upregulation in non-small-cell lung carcinoma cells

Comparative studies of macrophage-biased responses in mice to infection with Toxoplasma gondii ToxoDB #9 strains of different virulence isolated from China

Initiation and termination of NF-κB signaling by the intracellular protozoan parasite Toxoplasma gondii

Activation of NF-KB by Toxoplasma gondii correlates with increased expression of antiapoptotic genes and localization of phosphorylated IKB to the parasitophorous vacuole membrane

Toxoplasma gondii virulence factor rop18 inhibits the host nf-kb pathway by promoting p65 degradation

Toxoplasma gondii Prevents Chromatin Remodeling Initiated by TLR-Triggered Macrophage Activation

Excretory/secretory products from two Fasciola hepatica isolates induce different transcriptional changes and IL-10 release in LPS-activated bovine

Molecular cloning and characterisation of in vitro immune response against astacin-like metalloprotease Ace-MTP-2 from Ancylostoma ceylanicum

Toxoplasma gondii Modulates the Host Cell Responses: An Overview of Apoptosis Pathways

Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis

Inhibition of caspase activation and a requirement for NF=KB function in the Toxoplasma gondii-mediated blockade of host apoptosis

A novel form of NF-κB is induced by Leishmania infection: Involvement in macrophage gene expression

How to master the host immune system? Leishmania parasites have the solutions!

Leishmaniasis emergence in Europe

Mechanisms of Immune Evasion in Leishmaniasis

The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure

IL-10 mediates susceptibility to Leishmania donovani infection

The Rel subunit of NF-κB-like transcription factors is a positive and negative regulator of macrophage gene expression: Distinct roles for Rel in different macrophage populations

Leishmania major Amastigotes Induce p50/c-Rel NF-κB Transcription Factor in Human Macrophages: Involvement in Cytokine Synthesis

Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription

Leishmania amazonensis Subverts the Transcription Factor Landscape in Dendritic Cells to Avoid Inflammasome Activation and Stall Maturation. Front

Immunomodulatory Properties of Leishmania Extracellular Vesicles during Host-Parasite Interaction: Differential Activation of TLRs and NF-κB Translocation by Dermotropic and Viscerotropic Species

Leishmania aethiopica cell-to-cell spreading involves caspase-3, AkT, and NF-κB but not PKC-δ activation and involves uptake of LAMP-1-positive bodies containing parasites

Leishmania donovani activates hypoxia inducible factor-1α and miR-210 for survival in macrophages by downregulation of NF-κB mediated pro-inflammatory immune respons

Activation of phosphatidylinositol 3-kinase/akt and impairment of nuclear factor-κB: Molecular mechanisms behind the arrested maturation/activation state of leishmania infantum-infected dendritic cells

Clinical Use of Schistosoma mansoni Antigens as Novel Immunotherapies for Autoimmune Disorders

Helminths protect against type 1 diabetes: Effects and mechanisms

Helminth-excreted/secreted products are recognized by multiple receptors on DCs to block the TLR response and bias Th2 polarization in a cRAF dependent pathway

Inhibition of store-operated calcium entry in microglia by helminth factors: Implications for immune suppression in neurocysticercosis

Neurocysticercal antigens stimulate chemokine secretion from human monocytes via an NF-κB-dependent pathway

Induction of interferon-γ by Taenia crassiceps glycans and Lewis sugars in naive BALB/c spleen and peritoneal exudate cells

Differential Requirement for NF-κB Family Members in Control of Helminth Infection and Intestinal Inflammation

NF-κB1 (p50) homodimers differentially regulate pro-and anti-inflammatory cytokines in macrophages

The innate immune responses of colonic epithelial cells to Trichuris muris are similar in mouse strains that develop a type 1 or type 2 adaptive immune response

Nematode asparaginyl-tRNA synthetase resolves intestinal inflammation in mice with T-cell transfer colitis

A novel ligand of Toll-like receptor 4 from the sheath of Wuchereria bancrofti Microfilaria induces proinflammatory response in macrophages

Purinergic P2X7 receptor mediates the elimination of Trichinella spiralis by activating NF-κB/NLRP3/IL-1b pathway in macrophages

Immunomodulatory effects of Trichinella spiralis excretory-secretory antigens on macrophages

Regulation of cytokine expression in murine macrophages stimulated by excretory/secretory products from Trichinella spiralis in vitro

Infective larvae of Brugia malayi induce polarization of host macrophages that helps in immune evasion

Toll-like receptor-and filarial antigenmediated, mitogen-activated protein kinase-and NF-κB-dependent regulation of angiogenic growth factors in filarial lymphatic pathology

L4 stage Heligmosomoides polygyrus prevents the maturation of dendritic JAWS II cells

The antiapoptotic activity of Heligmosomoides polygyrus antigen fractions

Brugia malayi Microfilariae Induce Cell Death in Human Dendritic Cells, Inhibit Their Ability to Make IL-12 and IL-10, and Reduce Their Capacity to Activate CD4+ T Cells

Filarial lymphedema is characterized by antigen-specific Th1 and Th17 proinflammatory responses and a lack of regulatory T cells

The role of nuclear factor kappa B (NF-κB) in filarial pathology

NF-κB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement

Proinflammatory Cytokines Increase Vascular Endothelial Growth Factor Expression in

Brugia malayi asparaginyl-Trna synthetase stimulates endothelial cell proliferation, vasodilation and angiogenesis

Systemic Cytokine and Chemokine Profiles in Individuals With Schistosoma mansoni Infection and Low Parasite Burden

IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis

Slight activation of nuclear factor kappa-B is associated with increased hepatic stellate cell apoptosis in human schistosomal fibrosis

Activation of the NLRP3 and AIM2 inflammasomes in a mouse model of Schistosoma mansoni infection

A Boswellic acid-containing extract ameliorates schistosomiasis liver granuloma and fibrosis through regulating NF-κB signaling in mice

Genistein improves schistosomiasis liver granuloma and fibrosis via dampening NF-kB signaling in mice

The Fasciola hepatica tegumental antigen suppresses dendritic cell maturation and function

Fasciola hepatica-The pilot study of in vitro assessing immune response against native and recombinant antigens of the fluke

Fasciola hepatica isolates induce different immune responses in unmaturated bovine macrophages

Extracellular vesicles from the helminth Fasciola hepatica Prevent DSS-induced acute ulcerative colitis in a T-lymphocyte independent mode

Major secretory antigens of the Helminth Fasciola hepatica activate a suppressive dendritic cell phenotype that attenuates Th17 cells but fails to activate Th2 immune responses

Fasciola hepatica GST downregulates NF-κB pathway effectors and inflammatory cytokines while promoting survival in a mouse septic shock model

Fasciola hepatica fatty acid binding protein inhibits TLR4 activation and suppresses the inflammatory cytokines induced by LPS in vitro and in vivo

Upregulation of Toll-like receptor 2 and nuclear factor-kappa B expression in experimental colonic schistosomiasis

Cathepsin L3 from fasciola hepatica induces NLRP3 inflammasome alternative activation in murine dendritic cells

Mitochondrial dynamics in the mouse liver infected by Schistosoma mansoni